|
EP3345625B1 |
09 Dec, 2020
|
Pharmaceutical Composition And Administrations Thereof
|
Aug, 2029
|
3
| |
|
EP3880197B1 |
22 Feb, 2023
|
Methods Of Treatment For Cystic Fibrosis
|
Nov, 2039
|
2
| |
|
EP2914248B2 |
18 Oct, 2023
|
Pharmaceutical Compositions For The Treatment Of Cftr Mediated Diseases
|
NA
|
1
| |
|
EP3752510B1 |
07 Dec, 2022
|
Macrocycles As Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions Thereof, Their Use In The Treatment Of Cycstic Fibrosis, And Process For Making Them
|
Feb, 2039
|
1
| |
|
EP3798214B1 |
14 Sep, 2022
|
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
|
Oct, 2035
|
1
| |
|
EP3203840B1 |
05 Aug, 2020
|
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
|
Oct, 2035
|
1
| |
|
EP2464337B1 |
09 Jan, 2019
|
Pharmaceutical Composition And Administrations Thereof
|
NA
|
1
| |
|
EP3131582B1 |
23 May, 2018
|
Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases
|
NA
|
1
| |
